跳至主要内容
临床试验/NL-OMON54035
NL-OMON54035招募中4 期

ess Bleeding by Omitting Aspirin in Non-ST-segment Elevation Acute Coronary Syndrome Patients - LEGACY

Academisch Medisch Centrum0 个研究点目标入组 3,090 人开始时间: 待定最近更新:

试验速览

阶段
4 期
状态
招募中
入组人数
3,090

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 至 64(—)

入选标准

  • - Adult patients presenting with NSTE-ACS undergoing PCI
  • - Written informed consent

排除标准

  • - Known allergy or contraindication for aspirin or P2Y12-inhibitors
  • - Concurrent use of oral anticoagulants (e.g. because of atrial fibrillation)
  • - Overwriting indication for DAPT (e.g. recent PCI or ACS)
  • - Planned surgical intervention within 12 months of revascularization
  • - Pregnant or breastfeeding women at time of enrolment
  • - Participation in another trial with an investigational drug or device (i.e.

研究者

相似试验